China Resources Pharmaceutical hits over 3-year high on unit's strong Q1
** Shares of pharmaceutical and healthcare products maker
China Resources Pharmaceutical Group Ltd 3320.HK jump as much
as 9.7% to HK$7.70, highest since January 2020
** Stock on track for a second session of gains; top gainer
in Hang Seng Composite Index .HSCI
** Co says its unit Jiangzhong Pharmaceutical posts net
profit of 258 mln yuan ($37.33 mln) for three months ended
March, up 33.3% YOY, with\ revenue surging 41.4% YOY to 1.31 bln
yuan
** Hong Kong's healthcare index .HSCIH climbs 0.7%, the
Hang Seng Composite Index .HSCI gains 0.2% and Hang Seng Index
.HSI adds 0.3%
($1 = 6.9120 Chinese yuan renminbi)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million